In brief: Regenera, Compumedics, SciGen
Friday, 21 October, 2005
Regenera (ASX:RGA) has appointed Hon Dr Michael Woodridge as non-executive chairman effective immediately, subject to shareholder approval. Woodridge is a former federal minister for health and is currently chairman of Neurosciences Australia, the Cooperative Research Centre in Oral Health Science, Resonance Health (ASX:RHT), Dia-B (ASX:DIA) and a board member of Cogstate (ASX:CGS), Research Australia and the Centre for Eye Research Australia.
Koichiro Koike has resigned as a director of Compumedics (ASX:CMP) due to health reasons. The company has yet to decide on a replacement and when that will occur.
Dr Colin Goldschmidt and Chris Wilks will today step down as directors of SciGen (ASX:SIE) due to their time commitments to Sonic Healthcare, a company which spun out of SciGen in 2002.
AusBiotech partners with Tenmile
Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced...
Australian CDC issues update in wake of Ebola outbreak
After the WHO determined the outbreak of Ebola in the DRC and Uganda to be a public health...
Australia announces $7.2m diphtheria outbreak response package
To respond to the biggest diphtheria outbreak on record, support has been announced for the NT...
